Document date: October 27, 2011
Released online: October 27, 2011
Among the health promotion and cost-control strategies included in the Affordable Care Act (ACA) is a focus on disease prevention. In addition to bolstering coverage of clinical preventive services the ACA includes new funding for evidence-based lifestyle interventions targeting chronic diseases like diabetes, hypertension, heart disease, stroke and renal disease, all of which are growing in prevalence in the U.S. This brief examines the budgetary implications of unchecked prevalence growth, describes promising approaches to reducing that growth, and estimates the potential return on investment in these approaches as envisioned in the ACA, finding ample justification for these efforts in a larger cost-control strategy.
Other Publications by the Authors
Usage and reprints: Most publications may be downloaded free of charge from the web site and may be used and copies made for research, academic, policy or other non-commercial purposes. Proper attribution is required. Posting UI research papers on other websites is permitted subject to prior approval from the Urban Institute—contact email@example.com.
If you are unable to access or print the PDF document please contact us or call the Publications Office at (202) 261-5687.
Disclaimer: The nonpartisan Urban Institute publishes studies, reports, and books on timely topics worthy of public consideration. The views expressed are those of the authors and should not be attributed to the Urban Institute, its trustees, or its funders. Copyright of the written materials contained within the Urban Institute website is owned or controlled by the Urban Institute.